by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

SCA Pharmaceuticals, LLC Warning Letter Details

Warning Letter

SCA Pharmaceuticals, LLC

SCA Pharmaceuticals, LLC, 8821 Knoedl Court Little Rock , AR 72205-4600 United States

Issue DateSeptember 14, 2026

FEI NumberN/A

Violations6

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

SCA Pharmaceuticals, LLC FDA Warning Letter, September 14, 2026